Bellevue Group AG ALNY Holdings History
Bellevue Group AG's Alnylam Pharmaceuticals Inc Holding Summary
As of 2025-03-31, Bellevue Group AG held 768,147.00 shares of Alnylam Pharmaceuticals Inc(ALNY), totaling $207.42 Mil. This investment constitutes 4.65% of their stock portfolio, and Bellevue Group AG now holds 0.59% of the outstanding Alnylam Pharmaceuticals Inc(ALNY) stock.
The initial trade took place in 2018Q2. And since then Bellevue Group AG has made 11 purchases of ALNY, at an average price of $83.79, for a total of 2.08 Mil shares. In addition, there have been 17 sales at an average price of $166.25 for 1.32 Mil shares. Based on historical transaction data and ALNY's current price of $324.81, Bellevue Group AG's estimated gain on his ALNY holdings is $293.58 Mil, reflecting a 168.17% gain to date.
Bellevue Group AG ALNY ($324.81) Holding Chart
Bellevue Group AG ALNY ($324.81) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price $-/Share | ||
| Shares Sold | 0 | Average Price $-/Share | ||
| Current Price $0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
